Elevance Health Inc
NYSE:ELV
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
394.2
560.6041
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Elevance Health Inc
Wall Street
Price Targets
ELV Price Targets Summary
Elevance Health Inc
According to Wall Street analysts, the average 1-year price target for
ELV
is 531.436 USD
with a low forecast of 469.65 USD and a high forecast of 656.25 USD.
ELV Last Price Targets
Elevance Health Inc
The latest public price target was made on Oct 21, 2024 by
David Windley
from
Jefferies
,
who expects
ELV
stock to
rise by 31%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
David Windley
Jefferies
|
529
USD
Upside 31% |
1 month ago
Oct 21, 2024
|
Elevance (ELV) PT Lowered to $529 at Jefferies
StreetInsider
|
|
Whit Mayo
Leerink Partners
|
515
USD
Upside 27% |
1 month ago
Oct 21, 2024
|
Elevance (ELV) PT Lowered to $515 at Leerink Partners
StreetInsider
|
Ben Hendrix
RBC Capital
|
478
USD
Upside 18% |
1 month ago
Oct 18, 2024
|
Elevance (ELV) PT Lowered to $478 at RBC Capital
StreetInsider
|
David MacDonald
Truist Financial
|
520
USD
Upside 28% |
1 month ago
Oct 18, 2024
|
Elevance (ELV) PT Lowered to $520 at Truist Securities
StreetInsider
|
Sarah James
Raymond James
|
485
USD
Upside 20% |
1 month ago
Oct 18, 2024
|
These Analysts Cut Their Forecasts On Elevance Health Following Q3 Earnings
Benzinga
|
Michael Ha
Robert W. Baird
|
625
USD
Upside 54% |
1 month ago
Oct 16, 2024
|
Baird Reiterates Outperform Rating on Elevance (ELV)
StreetInsider
|
|
Ben Hendrix
RBC Capital
|
585
USD
Upside 45% |
4 months ago
Jul 18, 2024
|
Elevance Health price target raised to $585 from $575 at RBC Capital
TheFly
|
|
David MacDonald
Truist Financial
|
620
USD
Upside 53% |
4 months ago
Jul 15, 2024
|
Elevance Health price target raised to $620 from $600 at Truist
TheFly
|
Erin Wright
Morgan Stanley
|
643
USD
Upside 59% |
4 months ago
Jun 24, 2024
|
Elevance Health initiated with an Overweight at Morgan Stanley
TheFly
|
|
Michael Ha
Robert W. Baird
|
649
USD
Upside 60% |
5 months ago
May 29, 2024
|
Elevance Health initiated with an Outperform at Baird
TheFly
|
|
David Windley
Jefferies
|
604
USD
Upside 49% |
7 months ago
Apr 19, 2024
|
Elevance (ELV) PT Raised to $604 at Jefferies
StreetInsider
|
Stephen Baxter
Wells Fargo
|
600
USD
Upside 48% |
7 months ago
Apr 19, 2024
|
Elevance (ELV) PT Raised to $600 at Wells Fargo
StreetInsider
|
|
Ben Hendrix
RBC Capital
|
575
USD
Upside 42% |
7 months ago
Apr 19, 2024
|
Elevance (ELV) PT Raised to $575 at RBC Capital
StreetInsider
|
Andrew Mok
Barclays
|
621
USD
Upside 53% |
7 months ago
Apr 19, 2024
|
Elevance Health price target raised to $621 from $584 at Barclays
TheFly
|
AJ Rice
UBS
|
605
USD
Upside 49% |
7 months ago
Apr 19, 2024
|
Elevance (ELV) PT Raised to $605 at UBS
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ELV's stock price target?
Price Target
531.436
USD
According to Wall Street analysts, the average 1-year price target for
ELV
is 531.436 USD
with a low forecast of 469.65 USD and a high forecast of 656.25 USD.
What is Elevance Health Inc's Revenue forecast?
Projected CAGR
6%
For the last 8 years the
compound annual growth rate for
Elevance Health Inc's revenue is
10%.
The projected
CAGR
for the next 3 years is
6%.
What is Elevance Health Inc's Net Income forecast?
Projected CAGR
17%
For the last 8 years the
compound annual growth rate for
Elevance Health Inc's net income is
11%.
The projected
CAGR
for the next 3 years is
17%.
You don't have any saved screeners yet
